2009
DOI: 10.1007/s00455-009-9232-1
|View full text |Cite
|
Sign up to set email alerts
|

A Mouse Model of Pharyngeal Dysphagia in Amyotrophic Lateral Sclerosis

Abstract: We recently established that the SOD1-G93A transgenic mouse is a suitable model for oral-stage dysphagia in amyotrophic lateral sclerosis (ALS). The purpose of the present study was to determine whether it could serve as a model for pharyngeal-stage dysphagia as well. Electrophysiological and histological experiments were conducted on end-stage SOD1-G93A transgenic mice (n = 9) and age-matched wild-type (WT) littermates (n = 12). Transgenic mice required a twofold higher stimulus frequency (40 Hz) applied to t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
34
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 37 publications
(37 citation statements)
references
References 59 publications
3
34
0
Order By: Relevance
“…Further, the clinical presentation and progression of swallowing impairment and dysphagia in MND is heterogeneous – even between subtypes classic ALS, grouped by onset-type (i.e., bulbar- vs. spinal-onset). Several factors reported to influence or predict the severity and rate of progression of dysphagia in MND (particularly ALS), include: age at disease onset (i.e., older individuals often progress faster, require non-oral feeding sooner) [2729], sex (i.e., females often present with bulbar symptoms earlier, and possibly greater severity) [27,30,31], and symptom onset (i.e., bulbar-onset ALS and PBP show faster rate of decline, different clinical presentation) [13,15,30,32,29]. Disease duration and the length of time since onset of bulbar symptoms have also been reported as prognostic indicators of function and severity [29,33].…”
Section: Discussionmentioning
confidence: 99%
“…Further, the clinical presentation and progression of swallowing impairment and dysphagia in MND is heterogeneous – even between subtypes classic ALS, grouped by onset-type (i.e., bulbar- vs. spinal-onset). Several factors reported to influence or predict the severity and rate of progression of dysphagia in MND (particularly ALS), include: age at disease onset (i.e., older individuals often progress faster, require non-oral feeding sooner) [2729], sex (i.e., females often present with bulbar symptoms earlier, and possibly greater severity) [27,30,31], and symptom onset (i.e., bulbar-onset ALS and PBP show faster rate of decline, different clinical presentation) [13,15,30,32,29]. Disease duration and the length of time since onset of bulbar symptoms have also been reported as prognostic indicators of function and severity [29,33].…”
Section: Discussionmentioning
confidence: 99%
“…Ceteris paribus is inherent in the design of the study. The SOD1-G93A transgenic rodents are validated models of oral-stage dysphagia for bulbar deficits of Amyotrophic Lateral Sclerosis [28, 32]. There are multiple models of Parkinson’s disease, including (6-OHDA)-induced DA depletion [8, 37], surgical lesions [42] and PINK KO genetic models [22, 23].…”
Section: Ceteris Paribus and Understanding Pathophysiologymentioning
confidence: 99%
“…We and others have reported bulbar deficits in SOD1-G93A transgenic mice and rats (11, 12, 13, 14). These studies validate these models as representing the full range of symptoms in ALS.…”
Section: Discussionmentioning
confidence: 63%
“…Until recently, preclinical studies with SOD1-G93A rodents have focused almost exclusively on spinal deficits. We and others have reported orolingual motor deficits in SOD1-G93A mice (11, 12, 13) and rats (14) that are analogous to bulbar deficits in ALS. A previous study reported heterogeneity with regard to spinal deficits that relates to survival in SOD1-G93A rats (10).…”
Section: Introductionmentioning
confidence: 66%